Contrive Datum Insights has published "Disposable Resuscitation Devices Market Size, Share & Industry Analysis, By Product type (Manual Resuscitators (Bag Valve Mask), Disposable Anesthesia & CPR Masks, Oxygen Delivery Masks & Nasal Cannulas, Airway Management Devices), Type (Adult, Kid), Application (Hospital, Clinic), End user (Hospitals, Emergency Medical Services (EMS) & Pre-hospital, Ambulatory Surgical Centers, Home Care & Long-term Care), Distribution channel (Direct/Institutional Tenders, Distributors, Online & Retail Pharmacies), and Regional Forecast, 2026-2034". The study sizes the global disposable resuscitation devices market at USD 1.29 billion in 2025 and projects growth from USD 1.37 billion in 2026 to USD 2.18 billion by 2034, a compound annual growth rate of 5.98% across the forecast period.
Disposable resuscitation devices are single-use airway and ventilation support products, including bag valve masks, anesthesia and CPR masks, oxygen delivery masks and nasal cannulas, and oral and nasal airway adjuncts, used to restore or support a patient's breathing during cardiac arrest, surgery, trauma or respiratory failure. They are designed for one-time use and disposal after a single patient encounter, reducing cross-contamination risk compared with devices that must be cleaned and reused. Buyers include hospitals, ambulatory surgical centers, emergency medical services and, to a lesser extent, home care providers, all of whom stock these devices for immediate use in emergency and routine clinical settings.
Rising EMS infrastructure investment and ambulance fleet expansion
Rising EMS infrastructure investment and ambulance fleet expansion is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 5.98% a year, the product type lines exposed to it move fastest: Airway Management Devices compounds at 10.28%, taking its share of revenue from 11.6% to 16.1% and its value from USD 0.15 billion to USD 0.35 billion.
On the upside, the study's bull case assumes bull case assumes faster-than-expected single-use conversion in Asia Pacific and Latin America alongside accelerated EMS fleet expansion in emerging markets, which would take 2034 revenue to USD 2.47 billion rather than the USD 2.18 billion base case.
However, bear case assumes slower single-use conversion in cost-constrained public health systems and reduced hospital capital spending growth in key developed markets, which would hold 2034 revenue to USD 1.92 billion. Manual Resuscitators (Bag Valve Mask), which carries 41.9% of 2025 revenue, already grows at only 5.65% against the market's 5.98%, so the largest part of the base is also its slowest.
Key Players Compete on Manual Resuscitators (Bag Valve Mask) Volume and Airway Management Devices Growth
Competition in the global disposable resuscitation devices market runs along the product type axis rather than the regional one. Manual Resuscitators (Bag Valve Mask) holds 41.9% of 2025 revenue at USD 0.54 billion and remains the largest line through 2034 at 41.3%, making it the position hardest for a challenger to take. Airway Management Devices, growing at 10.28%, is where share actually changes hands. A supplier established in one is not thereby established in the other, which is what sustains a field of this size in a market of USD 1.29 billion.
Further Report Findings
| Segment | Led 2025 by | Share & value | Fastest-growing |
|---|---|---|---|
| Product type | Manual Resuscitators (Bag Valve Mask) | 41.9% · USD 0.54 billion | — |
| Type | Adult | 78% · USD 1.01 billion | Kid 7.12% |
| Application | Hospital | 71% · USD 0.92 billion | Clinic 7% |
| End user | Hospitals | 55% · USD 0.71 billion | Emergency Medical Services (EMS) & Pre-hospital 7.41% |
| Distribution channel | Direct/Institutional Tenders | 48% · USD 0.62 billion | Online & Retail Pharmacies 9.87% |
- Based on regional analysis, North America led the global disposable resuscitation devices market in 2025 with 34% of global revenue at USD 0.44 billion, reaching USD 0.68 billion by 2034.
- Asia Pacific takes a rising share of global revenue over the forecast period, from 24% in 2025 to 29% in 2034, with revenue growing from USD 0.31 billion to USD 0.63 billion.
- Middle East and Africa remains the smallest region throughout, at 7% of 2025 revenue and 7% by 2034.
- Airway Management Devices is projected to grow at 10.28% over the forecast period, the fastest of any product type line.
- The United States is the largest single country market at USD 0.37 billion in 2025, 28.7% of global revenue.
The report segments the market across five axes; by product type, and by type, application, end user and distribution channel; with revenue and a growth rate for every line in every year from 2020 to 2034, alongside bear, base and bull scenarios for the headline total at USD 1.92 billion and USD 2.47 billion by 2034. It covers all five regions with country-level breakdowns, the competitive landscape, and the research methodology behind every estimate. Delivered as a PDF; a free sample is available on request.